乌鲁木齐晚报全媒体讯（记者唐红梅 王丽丽 贾梦妍 王磊 牟敏 王媛媛 通讯员 罗丹丹）2026年的日历刚 刚翻开，乌鲁木齐正以昂扬之姿，奏响一曲激昂澎湃的"实干交响乐"。车间机器轰鸣、工地室内装修、 中欧班列鸣笛、键盘敲击跃动……在"十五五"开局之年，全市以"满格电量"进入状态，争分夺秒抓生 产、增产能、拓市场，全力奏响全年发展的宏伟序章。 第一个经开区新建综合型文化产业园："文化+"新地标轮廓清晰 位于喀什西路的乌鲁木齐疆酵文化产业园项目工地正在全面推进中。 新年伊始，位于喀什西路的乌鲁木齐疆酵文化产业园项目工地一片繁忙。作为市级重点项目，该项目总 建筑面积超6.6万平方米，由南北楼体通过空中连廊连接。目前，主体框架已拔地而起，整体轮廓清晰 可见。 第一批建材订单：瞄准国家级绿色矿山 在米东区化工工业园，新疆江南易泰建材公司生产线高速运转，正赶制来自哈密的订单。厂区内，新引 进的新能源矿用卡车往来穿梭。企业计划在2026年进一步提高固废再加工利用率，打造更可持续的建材 生产体系，力争产量同比增长20%。 公司党支部书记、总经理赵永卫介绍，企业将加大环保投入，推进矿区绿化与数字化矿山建设，争取达 到国家级绿色 ...

（来源：中国政府采购报） 处理结果：2025年5月，根据《中华人民共和国政府采购法》第七十七条第一款、《中华人民共和国政府采购法实施条例》第七十二条第一款第（二）项 规定，宜春市财政局依法对宜春市盛和建筑工程有限公司处以采购金额（100万元）千分之五（计5000元）的罚款，列入不良行为记录名单，在一年内禁 止参加政府采购活动。 二、鹰潭伟博贸易有限公司、江西瑞海医疗器械有限公司、江西卓顿远贸易有限公司串通投标案 案例简介：经调查，鹰潭伟博贸易有限公司、江西瑞海医疗器械有限公司、江西卓顿远贸易有限公司在奉新县人民医院门诊应急能力提升建设项目配套医 疗设备采购项目（二）彩色多普勒超声诊断仪项目（项目编号：JXTC2023040351-02C1）中投标报价呈规律性差异，属于《政府采购货物和服务招标投标 管理办法》（财政部令第87号)第三十七条第一款第（四）项规定的情形，上述3家公司已自认串通事实。根据《中华人民共和国政府采购法实施条例》第 七十四条第一款第（七）项规定，上述3家公司构成恶意串通。 处理结果：2025年6月，根据《中华人民共和国政府采购法》第七十七条第一款第（三）项之规定，奉新县财政局依法作出处罚如下 ...

天眼查App显示，近日，医联医通（上海）贸易有限公司成立，法定代表人为郭春荣，注册资本5万人 民币，经营范围为一般项目：货物进出口；第二类医疗器械销售；第二类医疗设备租赁；软件开发；电 子元器件制造；技术进出口；进出口代理；报关业务；报检业务。（除依法须经批准的项目外，凭营业 执照依法自主开展经营活动）自主展示（特色）项目：第一类医疗器械销售；第一类医疗设备租赁；机 械零件、零部件销售；机械电气设备销售；技术服务、技术开发、技术咨询、技术交流、技术转让、技 术推广；租赁服务（不含许可类租赁服务）；信息咨询服务（不含许可类信息咨询服务）；计算机软硬 件及辅助设备零售；软件销售；办公设备耗材销售；电气设备销售；专用设备修理；电气设备修理；仪 器仪表销售。 ...

Group 1 - The company announced the acquisition of 40% equity in Liaoning Guoke Hengtai Medical Technology Co., Ltd. from Shenyang Qianfu Yu Trading Partnership, which will result in the company holding 100% of the equity after the acquisition [1] - The initial valuation of the equity asset is set at 3.7658 million yuan, with the final price not exceeding the assessment results provided by the evaluation agency and the results filed with the state-owned property management authority [1] - The board of directors approved the acquisition without the need for a shareholders' meeting, indicating that the decision falls within the board's authority [1]

Group 1 - The Shanghai tax authority has implemented tax collection service measures to enhance the level of openness in the Pudong New Area, effectively stimulating foreign trade and investment vitality [1] - In the first half of the year, Pudong New Area processed export tax refunds exceeding 40 billion yuan, a year-on-year increase of 14.2%, and offshore trade stamp duty exemptions exceeded 200 million yuan, benefiting 1,300 enterprises [1] - The foreign reinvestment deferred tax amount increased by 208.5% year-on-year, indicating a significant boost in foreign investment activities [1] Group 2 - In the biopharmaceutical sector, Pudong New Area has pioneered the implementation of a tax policy for small enterprises seeking FDA certification, aiding small and medium-sized pharmaceutical companies in enjoying overseas certification fee exemptions [2] - The FDA certification tax policy has already benefited eight pharmaceutical companies, accelerating the internationalization of the biopharmaceutical industry in Pudong New Area [2] - The Shanghai tax authority aims to continue leveraging its tax functions to support stable foreign investment and trade through the implementation of 11 measures [2]

Group 1 - Company Yanguang Health Management is acquiring an 18.0% stake in Shanghai Ronggong Company from Fanghou No.1 [1] - The company will also subscribe for an additional 9.58% stake in Shanghai Ronggong through a capital increase agreement, with a total investment of RMB 12.72 million [1] - Following the completion of the capital increase, Yanguang Health Management will hold a total of 25.9% of Shanghai Ronggong [1] Group 2 - Yanguang Health Management is purchasing a 51.0% stake in Wuhan Ronggong for RMB 5.1 million, which will make Wuhan Ronggong a subsidiary of the company [2] - Shanghai Ronggong focuses on providing innovative financial technology solutions in the medical industry through its self-developed SaaS platform [2] - Wuhan Ronggong is involved in the wholesale and retail of various medical devices and has a significant market presence in the medical supply chain [2] Group 3 - The company aims to become a diversified imaging service provider for the entire medical imaging industry chain [3] - The strategic integration with Shanghai Ronggong and Wuhan Ronggong is expected to enhance the company's reach and create more business opportunities [3] - The acquisitions will enrich the company's financial tools and business models, promoting innovative solutions in imaging services [3]